{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T02:03:56Z","timestamp":1791597836331,"version":"4.3.4"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[1991,9,1]],"date-time":"1991-09-01T00:00:00Z","timestamp":683683200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Infection"],"published-print":{"date-parts":[[1991,9]]},"DOI":"10.1007\/bf01645371","type":"journal-article","created":{"date-parts":[[2005,5,7]],"date-time":"2005-05-07T17:21:55Z","timestamp":1115486515000},"page":"370-376","source":"Crossref","is-referenced-by-count":17,"title":["Cefpodoxime: Comparative antibacterial activity, influence of growth conditions, and bactericidal activity","Cefpodoxim: Vergleichende In-vitro-Aktivit\u00e4t, Einflu\u00df von Wachstumsbedingungen und Bakterizidie"],"prefix":"10.1007","volume":"19","author":[{"given":"H.","family":"Knothe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. M.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Eckardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"CR1","unstructured":"Chantot, J. F.: Antibacterial activity of cefpodoxime proxetil (RU 51807), a new orally active cephalosporin antibiotic. In: Program and Abstracts of the 16th International Congress of Chemotherapy, Jerusalem, June 11\u201316, 1989, p. 198."},{"key":"CR2","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1128\/AAC.31.7.1085","volume":"31","author":"Y. Utsui","year":"1987","unstructured":"Utsui, Y., Inoue, M., Mitsuhashi, S. In vitro andin vivo antibacterial activities of CS-807, a new oral cephalosporin. Antimicrob. Agents Chemother. 31 (1987) 1085\u20131092.","journal-title":"Antimicrob. Agents Chemother."},{"key":"CR3","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1093\/jac\/25.4.541","volume":"25","author":"R. Wise","year":"1990","unstructured":"Wise, R., Andrews, J. M., Ashby, J. P., Thornberry, D. Thein vitro activity of cefpodoxime; a comparison with other oral cephalosporins. J. Antimicrob. Chemother. 25 (1990) 541\u2013550.","journal-title":"J. Antimicrob. Chemother."},{"key":"CR4","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S0934-8840(11)80458-5","volume":"273","author":"W. Cullmann","year":"1990","unstructured":"Cullmann, W., Dick, W. Cefpodoxime: Comparable evaluation with other orally available cephalosporins with a note on the role of \u03b2-lactamases. Zentralbl. Bakteriol. 273 (1990) 501\u2013517.","journal-title":"Zentralbl. Bakteriol."},{"key":"CR5","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1128\/AAC.32.4.443","volume":"32","author":"R. N. Jones","year":"1988","unstructured":"Jones, R. N., Barry, A. L. Antimicrobial activity and disk diffusion susceptibility testing of U-76,253A (R-3746), the active metabolite of the new cephalosporin ester, U-76,252 (SC-807). Antimicrob. Agents Chemother. 32 (1988) 443\u2013449.","journal-title":"Antimicrob. Agents Chemother."},{"key":"CR6","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1128\/AAC.32.12.1896","volume":"32","author":"C. C. Knapp","year":"1988","unstructured":"Knapp, C. C., Sierra-Madero, J., Washington, J. A. Antibacterial activities of cefpodoxime, cefixime, and ceftriaxone. Antimicrob. Agents Chemother. 32 (1988) 1896\u20131898.","journal-title":"Antimicrob. Agents Chemother."},{"key":"CR7","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1128\/AAC.32.5.671","volume":"32","author":"N.-X. Chin","year":"1988","unstructured":"Chin, N.-X., Neu, H. C. In vitro activity on an oral iminomethoxy aminothiazolyl cephalosporin, R-3746. Antimicrob. Agents Chemother. 32 (1988) 671\u2013677.","journal-title":"Antimicrob. Agents Chemother."},{"key":"CR8","unstructured":"Thabaut, A., Meyran, M.: Comparative bactericidal activity of cefpodoxime. In:Rubinstein, E., Adam, D. (eds.): Proceedings of the 16th International Congress of Chemotherapy, Jerusalem, 1989. E. Lewin-Epstein LTD., Offset Printers, 1990, pp. 151.1\u20132."},{"key":"CR9","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1093\/jac\/23.4.509","volume":"23","author":"P. C. Appelbaum","year":"1989","unstructured":"Appelbaum, P. C., Spangler, S. K., Crotty, E., Jacobs, M. R. Susceptibility of penicillin-sensitive and -resistant strains ofStreptococcus pneumoniae to new antimicrobial agents, including daptomycin, teicoplanin, cefpodoxime and quinolones. J. Antimicrob. Chemother. 23 (1989) 509\u2013516.","journal-title":"J. Antimicrob. Chemother."},{"key":"CR10","unstructured":"Bauernfeind, A., Schweighart, S.: Cefpodoximein vitro activity. In: Program and Abstracts of the 16th International Congress of Chemotherapy, Jerusalem, June 11\u201316, 1989, p. 200."},{"key":"CR11","unstructured":"Dabernat, H., Avril, J. L., Weber, P., Boussougant, Y.: In vitro antibacterial activity of cefpodoxime (RU 51746) and other oral cephalosporins againstH. influenzae, B. catarrhalis, S. pneumoniae andStreptococcus spp. In: Program and Abstracts of the 16th International Congress of Chemotherapy, Jerusalem, June 11\u201316, 1989, p. 199."},{"key":"CR12","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1128\/AAC.32.7.1082","volume":"32","author":"R. J. Fass","year":"1988","unstructured":"Fass, R. J., Helsel, V. L. In vitro activity of U-76,252 (CS-807), a new oral cephalosporin. Antimicrob. Agents Chemother. 32 (1988) 1082\u20131085.","journal-title":"Antimicrob. Agents Chemother."},{"key":"CR13","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1128\/AAC.33.11.1878","volume":"33","author":"P. M. Mendelman","year":"1989","unstructured":"Mendelman, P. M., Henritzy, L. L., Chaffin, D. O., Lent, K., Smith, A. L., Stull, T. L., Wiley, E. A. In vitro activities and targets of three cephem anticiotics againstHaemophilus influenzae. Antimicrob. Agents Chemother. 33 (1989) 1878\u20131882.","journal-title":"Antimicrob. Agents Chemother."},{"key":"CR14","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1128\/AAC.33.1.113","volume":"33","author":"F. A. Sarubbi","year":"1989","unstructured":"Sarubbi, F. A., Verghese, A., Caggiano, C., Holtsclaw-Berk, S., Berk, S. L. In vitro activity of cefpodoxime proxetil (U-76,252;CS-807) against clinical isolates ofBranhamella catarrhalis. Antimicrob. Agents Chemother. 33 (1989) 113\u2013114.","journal-title":"Antimicrob. Agents Chemother."},{"key":"CR15","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1007\/BF01968153","volume":"8","author":"E. E. Stobberingh","year":"1989","unstructured":"Stobberingh, E. E., Houben, A. W., Philips, J. H. In vitro activity of cefpodoxime, a new oral cephalosporin. Eur. J. Clin. Microbiol. Infect. Dis. 8 (1989) 656\u2013658.","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"CR16","unstructured":"Wiedemann, B., Z\u00fchlsdorf, M. T.: Antibacterial activity of cefpodoxime proxetil. In: Program and Abstracts of the 16th International Congress of Chemotherapy, Jerusalem, June 11\u201316, 1989, p. 199."},{"key":"CR17","unstructured":"Yagi, B. H., Zurenko, G. E.: In vitro antibacterial activity of U-76,252 (CS-807), an orally-active cephalosporin antibiotic. 27th Interscience Conference on Antimicrobial Agents and Chemotherapy, New York, October 4\u20137, 1987, Abstract no. 657."},{"key":"CR18","unstructured":"Bille, J., Kaehler, D., Glauser, M. P.: In vitro activity against staphylococci and streptococci of cefpodoxime proxetil (RU 51807). In:Rubinstein, E., Adam, D. (eds.): Proceedings of the 16th International Congress of Chemotherapy, Jerusalem, 1989. E. Lewin-Epstein LTD., Offset Printers, 1990, pp. 151.1\u20132."},{"key":"CR19","unstructured":"Peters, G., Schumacher-Perdreau, F.: In vitro activity of cefpodoxime against staphylococci in comparison to 5 other cephalosporins. In: Program and Abstracts of the 16th International Congress of Chemotherapy, Jerusalem, June 11\u201316, 1989, p. 198."},{"key":"CR20","unstructured":"Monteil, H., Piemont, Y.: Staphylococcus aureus, S. epidermidis, S. saprophyticus, in vitro susceptibilities to the new orally active cephem antibiotic: Cefpodoxime proxetil. In:Rubinstein, E., Adam, D. (eds.): Proceedings of the 16th International Congress of Chemotherapy, Jerusalem, 1989. E. Lewin-Epstein LTD., Offset Printers, 1990, pp. 153.1\u20132"}],"container-title":["Infection"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01645371.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01645371\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01645371","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,7]],"date-time":"2019-05-07T12:32:53Z","timestamp":1557232373000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01645371"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1991,9]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1991,9]]}},"alternative-id":["BF01645371"],"URL":"https:\/\/doi.org\/10.1007\/bf01645371","relation":{},"ISSN":["0300-8126","1439-0973"],"issn-type":[{"value":"0300-8126","type":"print"},{"value":"1439-0973","type":"electronic"}],"subject":[],"published":{"date-parts":[[1991,9]]}}}